Eli Lilly

Vaxcyte

UnitedHealth Group

Lantheus Holdings

Option Care Health

Masimo

Pfizer

DexCom

AbbVie

Insulet

Harbor Health Care ETF

MEDI seeks long-term capital growth by actively managing a narrow portfolio of stocks engaged in the health care sector globally.

iShares U.S. Pharmaceuticals ETF

iShares U.S. Healthcare ETF

Horizon Kinetics Medical ETF

Health Care Select Sector SPDR Fund

Eli Lilly and Company (LLY) posted robust fourth-quarter 2023 earnings, beating estimates on both the top and bottom lines driven by strong sales of its diabetes and weight-loss treatments.

ETFs to Buy as Mounjaro Powers Eli Lilly's Q4 Earnings Beat

iShares U.S. Healthcare Providers ETF

Vanguard Health Care ETF

The largest U.S. health insurer UnitedHealth Group (UNH) reported better-than-expected fourth-quarter 2023 results but medical costs rose more than expected for the first time in two years.

UnitedHealth Beats on Q4 Earnings, Shares Slip: ETFs in Focus

Eli Lilly (LLY) posted robust third-quarter 2023 earnings results, beating estimates on both the top and bottom lines. Its Mounjaro anti-obesity drug continued its robust performance.

Eli Lilly Beats on Q3 Earnings: ETFs to Buy

UnitedHealth (UNH) reported better-than-expected third-quarter 2023 results. Earnings and revenues breezed past the Zacks Consensus Estimate.

UnitedHealth Beats on Q3 Earnings, Raises View: ETFs to Gain

Eli Lilly (LLY) experienced its most significant surge in stock prices in over two decades following the release of an impressive second-quarter 2023 earnings report and an optimistic outlook. ETFs having the largest exposure to the drug maker could be compelling picks to tap the strong growth.

Eli Lilly Soars on Blockbuster Q2 Earnings: ETFs to Tap

UnitedHealth (UNH) reported better-than-expected second-quarter 2023 results, breezing past the Zacks Consensus Estimate for earnings and revenues. The company lifted the lower end of its full-year earnings guidance.

UnitedHealth Beats Q2 Earnings, Updates View: ETFs to Gain

DiCE Molecules Holding LLC

VanEck Vectors Pharmaceutical ETF

Eli Lilly (LLY) has agreed to acquire DICE Therapeutics (DICE) in a cash deal worth approximately $2.4 billion. This strategic move is part of Eli Lilly's efforts to bolster its immunology pipeline, specifically targeting immune disease-related treatments.

ETFs to Capitalize on Eli Lilly's Buyout of DICE Therapeutics

UnitedHealth Group reported better-than-expected first-quarter 2023 results, breezing past the Zacks Consensus Estimate for earnings and revenues.

UnitedHealth's Solid Q1 Earnings Put These ETFs in Focus

Harbor Dividend Growth Leaders ETF

Harbor ETF Trust - Harbor Corporate Culture ETF

Harbor Corporate Culture Leaders ETF

Harbor Energy Transition Strategy ETF

Thematic investments are seeing a resurgence in investor interest after developing a – perhaps undeserved and unwarranted – negative reputation in recent years. The economic regime has shifted, and passive index funds aren't offering the returns they did in the post-global financial crisis decade.

Harbor CIO Kristof Gleich: Thematics Help Advisors Connect With Clients

UnitedHealth Group (UNH) breezed past the Zacks Consensus Estimate for earnings.

UnitedHealth Beats Q4 Earnings: ETFs in Focus

Invesco Taxable Municipal Bond ETF

Franklin Investment Grade Corporate ETF

AGF Global Infrastructure ETF

iShares Core S&P Small Cap ETF

Quadratic Interest Rate Volatility and Inflation ETF

Invesco S&P 500 Equal Weight Energy ETF

iShares 1-3 Year Treasury Bond ETF

iShares TIPS Bond ETF

These are the questions on every investor's mind: Have markets really priced in the severity of the Fed's campaign against inflation? How bad would a 2023 recession be — if there is one at all?

3 Ways to Play iShares' 2023 Hot Takes With ETFs

Harbor Capital Advisors has launched a new active, fully transparent ETF, providing advisors the opportunity to invest in a pure play healthcare strategy.

Harbor Launches Active Pure Play Healthcare ETF: MEDI

CHICAGO--(BUSINESS WIRE)--Harbor Capital Advisors, Inc. (“Harbor”), a premier multi-manager investment firm offering access to innovative and specialized expertise across a range of investment strategies and vehicles, today announced that it is adding to its exchange-traded fund (ETF) lineup by bringing a new Harbor Health Care ETF (MEDI) to market in November, upon completion of the registration process. This offering is in addition to the firm's growing lineup of ETFs across investment themes

News for Harbor Health Care ETF ETF (MEDI)